Medication info
Rivaro Phenocapsule 2/110 mg (Pitavastatin Calcium Hydrate, Fenofibric Acid)

Rivaro Phenocapsule 2/110 mg (Pitavastatin Calcium Hydrate, Fenofibric Acid)

Prescription medicationTabletOral
Ingredient · strength
Fenofibric Acid›110mg / 1 capsulePitavastatin Calcium Hydrate›2.205mg / 1 capsule
Manufacturer / importer
JW Pharmaceutical Corp.
Appearance
It is a hard capsule with a green upper part and a white lower part containing white round film-coated tablets and white rectangular enteric-coated film tablets.
Packaging
30 capsules/box [10 capsules/PTP*3]
Approval status
Active

MFDS item code 202501340 · Approved 2025.05.29 · Insurance code 644915380

Summary

Main use
Treatment of mixed dyslipidemia
Who takes it
Adults
Adult dose
The recommended dose is 1 capsule once daily, regardless of meals.

Ingredients

Manufacturer
JW Pharmaceutical Corp.

Efficacy & effects

Treatment of mixed dyslipidemia

  • Coronary artery disease
  • abnormal LDL-cholesterol levels
  • elevated triglyceride levels
  • decreased HDL-cholesterol levels
  • mixed dyslipidemia
View approved original text

Pitavastatin 2 mg monotherapy effectively manages LDL-cholesterol levels in high-risk adults for coronary artery disease. However, this treatment alone may have limited effects on improving elevated triglycerides and low HDL-cholesterol in mixed dyslipidemia. Therefore, it is also important to manage other dyslipidemia levels alongside LDL-cholesterol management in such patients. Pitavastatin is primarily used to lower LDL-cholesterol levels, reducing the risk of cardiovascular disease.

How to take

Adult dose

The recommended dose is 1 capsule once daily, regardless of meals.

Precautions

This medicine may affect the muscles, so if any symptoms such as muscle pain, weakness, or cramps occur during treatment, consult a physician immediately. Particularly, elderly patients over 65 years, women, patients with impaired kidney function, those with uncontrolled hypothyroidism, patients with a family history of muscular disorders or previous experience with muscular toxicity should be more cautious. This drug may affect liver function, so regular liver function tests should be conducted before and during treatment, and if liver function tests show a significant increase, medication should be stopped. This drug should not be used in patients with moderate to severe renal impairment, and caution is advised in patients with mild renal impairment. The risk of muscle toxicity may increase when taken with other lipid-lowering agents or specific medications, so careful monitoring is required according to a physician's guidance during concurrent use. This drug should not be administered to pregnant or potentially pregnant women, lactating women, or children under 18 years of age. If surgery is planned, this drug should be temporarily discontinued a few days before the procedure, and it can also be stopped in the event of serious clinical situations. Blood lipid levels should be checked regularly during treatment to evaluate therapeutic effects, and if there is no effect within 3 months, discontinuation should be considered. Rarely, hypersensitivity reactions such as skin rash, fever, and systemic symptoms or severe skin reactions may occur, so if any abnormal symptoms occur, consult a physician immediately. This drug may cause symptoms like dizziness, so caution is necessary when driving or operating machinery. There is no specific antidote for overdose, so appropriate treatment should be provided according to symptoms, and this drug is not removed by dialysis. Keep out of reach of children, and store in the original container to prevent misuse or deterioration in quality.

Side effects

Nasopharyngitis, upper respiratory tract infection, increased ALT, increased AST, increased GGT, abnormal liver function tests, gastroesophageal reflux disease, nausea, headache, dizziness, increased CPK, hypertension, chronic gastritis, erosive gastritis, decreased hemoglobin, decreased leukocyte count, decreased platelets, decreased granulocytes, leukopenia, increased eosinophils, increased leukocytes, elevated globulin, positive Coombs test, anemia, hypersensitivity, headache, fatigue, dizziness, stiffness, drowsiness, insomnia, heaviness, paralysis, thromboembolism, interstitial lung disease, gastrointestinal symptoms (abdominal pain, nausea, vomiting, diarrhea, bloating), pancreatitis, thirst, dyspepsia, abdominal pain, abdominal bloating, constipation, stomatitis, vomiting, loss of appetite, glossitis, nausea, gastric discomfort, diarrhea, increased transaminases, cholelithiasis, jaundice, complications of cholelithiasis, elevated bilirubin, increased cholinesterase, increased AST, increased ALT, increased γ-GT, increased ALP, increased LDH, decreased aldosterone, increased aldosterone, increased adrenocorticotropic hormone, increased cortisol, decreased testosterone, severe skin reactions, cutaneous hypersensitivity, rash, pruritus, urticaria, alopecia, photosensitivity, muscle disorders, myalgia, myositis, muscle cramps, weakness, renal failure, rhabdomyolysis, myopathy, muscle cramps, increased myoglobin, increased CPK, fatigue, frequent urination, increased BUN, increased serum creatinine, sexual dysfunction, increased homocysteine levels, increased hematuria, palpitations, fatigue, cutaneous pain, burning sensation, arthralgia, edema, blurred vision, photophobia, hearing loss, urinary hematuria, increased uric acid levels, increased serum potassium and phosphorus, dysgeusia, discolored urine, malaise, positive antinuclear antibodies, hypersensitivity, urticaria, rash, erythema, angioedema, pancreatitis, sleep disturbances, memory loss, depression, sexual dysfunction, diabetes, immune-mediated necrotizing myopathy, severe muscle weakness, ocular myasthenia, facial swelling, edema, arm swelling, hypersensitivity, paresthesia, insomnia, appetite loss, elevated blood pressure, chest discomfort, weakness, abdominal pain, dyspepsia, thirst, constipation, nausea, increased γ-GT, increased LDH, increased ALP, pruritus, urticaria, thrombocytopenia, increased serum creatinine, increased BUN, elevated blood pressure, paresthesia, chest discomfort

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a tightly closed container to protect it from air or moisture. The appropriate storage temperature is room temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

It is a hard capsule with a green upper part and a white lower part containing white round film-coated tablets and white rectangular enteric-coated film tablets.

Package unit

30 capsules/box [10 capsules/PTP*3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.